|
End-of-day quote
Australian S.E.
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 2011-02-28 |
| Corporate Officer/Principal | - | 2011-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 2011-02-28 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.59% | -3.68% | +39.04% | +111.76% | 1,025B | |
| -1.25% | -5.73% | +37.48% | +64.80% | 623B | |
| +0.87% | -0.98% | +10.64% | +76.55% | 459B | |
| -0.25% | -3.49% | +60.41% | +40.01% | 355B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 336B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 270B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 247B | |
| -0.86% | -2.81% | +35.50% | +51.32% | 220B | |
| -2.18% | -4.33% | +30.60% | +94.87% | 183B | |
| Average | -0.91% | -1.89% | +26.94% | +56.85% | 413.14B | |
| Weighted average by Cap. | -0.73% | -2.11% | +30.23% | +68.55% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
